phenofAST

phenofAST Overview

phenofAST has developed a fast and affordable clinical diagnostic solution for antibiotic susceptibility testing, providing definitive test results within 4 hours from a positive culture. Antibiotic susceptibility tests (AST) can take 2 to 3 days to produce definitive results, and with the accelerated spread of antibiotic-resistant bacteria, inappropriate antibiotic treatment results in mortality, morbidity, and higher healthcare costs across all stakeholders. phenofAST is the only company to have completely new & innovative physics-based technology, detecting cell division through laser light interferences, powered by AI analysis. phenofASTs solution provides same day AST test results in a cost effective way for a wide range of indications. This solution is applicable to any microbiology lab due to it's modular design – fit any lab space and needs, Green, minimal waste operation and low price of disposable testing cassette. With phenofAST solution, the microbiology lab will be able to provide the physician with the AST results, enabling the physician to adjust the antibiotic treatment on the same day that the patient was admitted, minimizing AMR ( antimicrobial resistance) and maximizing the right and effective treatment needed. Clinical validations done so far provided very high agreement with the gold standard. phenofAST goal is to become the Standard of Practice in antibiotic susceptibility testing, proving fast, cost-effective and wide-range solution for healthcare providers and payers.

Cumulative Funding Raised Over Time ($)

Latest News

Jun 14, 2021 · www.prweb.com

growth-positive

MindUP Invests in its 14th Portfolio Company: phenofAST

MindUP, a leading Israeli digital health incubator, has welcomed phenofAST to its portfolio of companies. phenofAST is developing a bio-convergent AST solution to address the growing threat of antimicrobial resistance. Their first product focuses on urinary tract infections and aims to provide definitive results of antimicrobial susceptibility testing in just 4 hours. This will enable clinicians to prescribe the right antibiotic more quickly, reducing the incidence of AMR and improving patient outcomes. MindUP sees phenofAST as an exciting addition to their portfolio and is committed to supporting the companys vision.

Partners

Funding

Team Members

3

Employees: 1-10

Web & Social Links

Locations

Haifa, Israel

Photos & Videos

1 item(s)

phenofAST Internal

Recent Updates

No update log entries.

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info